[HTML][HTML] Post-COVID-19-associated morbidity in children, adolescents, and adults: a matched cohort study including more than 157,000 individuals with COVID-19 in …

…, B Bertele, U Repschläger, N Richter, C Riederer… - PLoS …, 2022 - journals.plos.org
Background Long-term health sequelae of the Coronavirus Disease 2019 (COVID-19) are a
major public health concern. However, evidence on post-acute COVID-19 syndrome (post-…

[HTML][HTML] Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study

…, S Baßler, B Bertele, T Bitterer, C Riederer… - Clinical …, 2023 - Springer
Objectives To investigate whether the risk of developing an incident autoimmune disease is
increased in patients with prior COVID-19 disease compared to those without COVID-19, a …

Post COVID-19 in children, adolescents, and adults: results of a matched cohort study including more than 150,000 individuals with COVID-19

…, B Bertele, U Repschläger, N Richter, C Riederer… - MedRxiv, 2021 - medrxiv.org
Background Long-term health sequelae of the coronavirus disease 2019 (COVID-19) are a
major public health concern. However, evidence on post-acute COVID-19 syndrome (post …

[HTML][HTML] Quality of life and healthcare costs of patients with allergic respiratory diseases: a cross-sectional study

…, A Sperl, T Werfel, E Hamelmann, C Riederer… - The European Journal of …, 2023 - Springer
Background Allergic rhinitis (AR) and allergic asthma (AA) are chronic respiratory diseases
that represent a global health problem. One aim of this study was to analyze the Health-…

Large cohort study shows increased risk of developing atopic dermatitis after COVID-19 disease

…, S Baßler, B Bertele, T Bitterer, C Riederer… - …, 2024 - pubmed.ncbi.nlm.nih.gov
… 6 , Cordula Riederer

[HTML][HTML] Development of a risk score to identify patients at high risk for a severe course of COVID-19

…, B Bertele, U Repschläger, N Richter, C Riederer… - Journal of Public …, 2023 - Springer
Aim We aimed to develop a risk score to calculate a person’s individual risk for a severe
COVID-19 course (POINTED score) to support prioritization of especially vulnerable patients for …

Care with allergen immunotherapy for allergic respiratory diseases in Germany—Predictors and deficits

…, T Werfel, E Hamelmann, C Riederer… - Clinical & …, 2022 - Wiley Online Library
Background Allergen immunotherapy (AIT) represents the only possibility of causal therapy
for allergic respiratory diseases. Although the prevailing high prevalence of allergic diseases …

Correction to: incident autoimmune diseases in association with SARS-Cov-2 infection: A matched cohort study

…, S Baßler, B Bertele, T Bitterer, C Riederer… - Clinical …, 2023 - ncbi.nlm.nih.gov
… Falko Tesch, corresponding author 1 Franz Ehm, 1 Annika Vivirito, 2 Danny Wende, 3
Manuel Batram, 4 Friedrich Loser, 5 Simone Menzer, 6 Josephine Jacob, 2 Martin Roessler …

[HTML][HTML] Prescription of opioid analgesics for non-cancer pain in Germany: Study protocol for a mixed methods analysis

…, C Abels, N Blase, GD Giebel, C Riederer… - Journal of Public …, 2023 - Springer
Aim Long-term therapy with opioid analgesics bears the risk of complications, such as misuse,
abuse, and dependence. An evidence-based guideline addresses the long-term use of …

[HTML][HTML] Health care situation in patients with allergic respiratory diseases with special focus on specific immunotherapy

F Valbert, S Neusser, C Riederer… - Allergo Journal …, 2021 - Springer
Background Allergic respiratory diseases have an impact on the performance and quality of
life of the patients. The allergen immunotherapy (AIT) is the only causal treatment approach …